Archived Webinars

TASA ID: 22108

The quest for innovative treatments in mental health care has led to a resurgence of interest in psychedelic therapeutics. This renewed focus is not without merit; emerging research suggests that substances like psilocybin and DMT may offer novel approaches to treating complex mental health conditions that have long challenged conventional medical paradigms. An in-depth interview with Doug Drysdale, CEO of Cybin, a company at the forefront of this exploration, provides a comprehensive look at the science, the potential, and the pragmatic considerations involved in bringing psychedelic-based treatments from theory to practice.

TASA ID: 22108

"Why settle for less when you can have more?" This question echoes throughout the halls of Ketamine Clinics Los Angeles, a leading  mental health treatment center located in Los Angeles, CA.. Sam Mandel, the co-founder and CEO of Ketamine Clinics Los Angeles, sheds light on this revolutionary treatment in a recent interview with me, offering a refreshing  perspective on how society can tackle the current mental health epidemic.

TASA ID: 22108

In our rapidly evolving world, telehealth is taking center stage, transforming lives and revolutionizing healthcare delivery. However, one particular niche stands out: the treatment of eating disorders. With the rise of remote work and telehealth, a new era is dawning that brings unique opportunities for patients and providers alike. It’s part of a broader transformation in remote work - and life.

TASA ID: 22108

Imagine you put on an old coat that you have not worn in a while, and to your surprise find a crumpled $20 bill in your pocket. How good does it feel? Do you go up half a notch on a one to 10 mood scale, or maybe a full notch?

Let’s imagine a different scenario. You’re buying ice cream from an ice cream cart and take out a $20 bill to pay. Suddenly, a gust of wind sweeps it from your hand and into a nearby sewer grate. What does that do to your mood on the one-to-10 scale?

TASA ID: 22108

Imagine you are driving along the highway, and see an electric sign saying, “79 traffic deaths this year.” Would this make you less likely to crash your car shortly after seeing the sign? Perhaps you think it would have no effect.

Neither are true. According to a recent peer-reviewed study that just came out in Science, one of the world’s top academic journals, you would be more likely to crash, not less. Talk about unintended consequences!

The study examined seven years of data from 880 electric highway signs, which showed the number of deaths so far this year for one week each month as part of a safety campaign. The researchers found that the number of crashes increased by 1.52% within three miles of the signs on these safety campaign weeks compared to the other weeks of the month when the signs did not show fatality information.

That is about the same impact as raising the speed limit by four miles or decreasing the number of highway troopers by 10%. The scientists calculated that the social costs of such fatality messages amount to $377 million per year, with 2,600 additional crashes and 16 deaths.